Vanadium nasal exposure gains traction as rodent smell-loss model
Bottom line
A new review in Animals highlights intranasal vanadium exposure as a useful rodent model for studying toxicant-induced olfactory dysfunction, a problem that’s drawing more attention as researchers examine how inhaled environmental agents can damage the nose-brain pathway. The review, by Margarida Pereira, Sofia Alves-Pimenta, and Carlos Venâncio, synthesizes evidence that vanadium pentoxide delivered through the nasal route can injure the olfactory epithelium, alter olfactory bulb structure, and impair odor-driven behavior in rodents. Supporting data from the authors’ recent rat work showed dose-dependent injury, with exposed animals taking longer in odor-based testing and showing epithelial necrosis, loss of olfactory sensory neurons, and structural disruption in the olfactory bulb. (pubmed.ncbi.nlm.nih.gov)
Why it matters: For veterinary researchers and clinicians, the model offers a controlled way to study a sensory deficit that’s relevant to both environmental toxicology and neurodegenerative disease research. Vanadium is an established inhalation toxicant, and government toxicology summaries have linked inhaled vanadium pentoxide with nasal and olfactory epithelial injury in rodents, giving the model real-world exposure relevance even if it remains preclinical. That could make it useful for testing biomarkers, regenerative responses in the olfactory epithelium, and potential therapies aimed at smell loss or broader nose-to-brain neurotoxicity. (ncbi.nlm.nih.gov)
What to watch: Expect follow-up work on standardizing dosing, validating translational biomarkers, and testing whether this model can help evaluate interventions for toxicant-related smell loss and early neurodegenerative change. (frontiersin.org)
Key facts
- Study type
- Review in Animals
- Topic
- Intranasal vanadium exposure as a rodent model for olfactory dysfunction
- Agent
- Vanadium pentoxide
- Route
- Intranasal
- Species
- Rodents
- Key finding
- Exposure can injure the olfactory epithelium, alter olfactory bulb structure, and impair odor-driven behavior
- Rat study doses
- 182 µg and 273 µg
- Observed effects
- Dose-dependent epithelial necrosis, loss of olfactory sensory neurons, and olfactory bulb disruption
- Publication date
- September 22, 2025
A new paper in Animals puts a spotlight on intranasal vanadium exposure as a rodent model for olfactory dysfunction, arguing that it can help researchers study how inhaled toxicants damage the olfactory system and potentially reach the central nervous system through the nose-brain route. The topic builds on a broader literature showing that vanadium pentoxide, an inhaled metal toxicant, can impair smell-related behavior and injure olfactory tissues in laboratory animals. (pubmed.ncbi.nlm.nih.gov)
The interest here is larger than smell alone. Olfactory dysfunction is increasingly studied as both a direct toxicologic outcome and a possible early marker of wider neurologic injury. That makes rodent models valuable, because they let investigators control dose, route, and timing while examining the olfactory epithelium, olfactory bulb, and downstream brain regions in detail. The authors’ recent rat study, published in Frontiers in Neuroanatomy on September 22, 2025, appears to provide much of the experimental backbone for the review. (frontiersin.org)
In that rat study, intranasal vanadium pentoxide was delivered at 182 µg and 273 µg doses, and both exposure groups showed measurable injury. Rats underwent buried food and olfactory habituation testing to assess odor detection and discrimination, and the higher-dose group showed more pronounced dysfunction. Histology found epithelial disorganization, vacuolization of sustentacular cells, coagulative necrosis, histiocytic infiltration, and reduced neuronal cell density in the olfactory epithelium, consistent with marked loss of olfactory sensory neurons. The olfactory bulb also showed reduced glomerular density and structural disorganization, especially at the higher dose. (frontiersin.org)
The paper also points to biologic signals that could matter for future translational work. Investigators reported increased PCNA-positive cells in the olfactory epithelium, suggesting a regenerative or proliferative response after injury, and greater GFAP-positive astrocyte accumulation in the olfactory bulb and hippocampus, consistent with neuroinflammatory activation. At the same time, the oxidative stress picture was more mixed than expected, with some detoxification pathway activation but no dramatic shift across all classic redox markers under the tested conditions. (frontiersin.org)
This model also fits with older toxicology evidence. Earlier mouse work found that intranasal vanadium exposure adversely affected the olfactory bulbs and produced neurobehavioral and neurochemical impairments. Separately, the ATSDR toxicological profile for vanadium summarizes inhalation studies showing nasal lesions, goblet cell hyperplasia, and olfactory epithelial atrophy in rodents exposed to vanadium pentoxide over longer periods. Together, those findings strengthen the case that this is not just an artificial lab phenotype, but one anchored in known inhalation toxicology. (pmc.ncbi.nlm.nih.gov)
Expert commentary specific to the new Animals review was limited in public sources, but the surrounding literature frames vanadium exposure as part of a wider concern about environmentally linked neurotoxicity. Reviews of metal neurotoxicity have cited olfactory impairment after vanadium exposure and discussed its relevance to Parkinson’s disease-related pathways and other neurodegenerative mechanisms. That doesn’t mean the rodent findings translate directly to clinical veterinary patients, but it does explain why the model may attract attention beyond basic nasal pathology. (pmc.ncbi.nlm.nih.gov)
Why it matters: For veterinary professionals, especially those in research, pathology, toxicology, and comparative neurology, this model could become a practical tool for studying how inhaled contaminants injure sensory tissue and trigger downstream brain effects. It may also help investigators test candidate biomarkers of olfactory injury, characterize repair in the olfactory epithelium, and compare environmental toxicant effects across species. While this is still experimental work in rodents, it speaks to broader questions that matter in veterinary medicine, including environmental exposure risk, sentinel pathology, and the overlap between sensory dysfunction and neurologic disease. (frontiersin.org)
What to watch: The next step is likely refinement rather than reinvention, including reproducible dosing schemes, longer-term outcome studies, and intervention trials to see whether the model can support therapeutic testing or earlier detection of toxicant-related olfactory injury. Researchers may also try to connect nasal pathology more clearly with functional endpoints and with biomarkers that could eventually be useful in comparative or translational settings. (frontiersin.org)